Figure 1
From: Pitavastatin in cardiometabolic disease: therapeutic profile
Pitavastatin presents greater high-density lipoprotein-elevating and apolipoprotein A-1-elevating efficacy than atorvastatin. Pitavastatin has more significant high-density lipoprotein (HDL)-elevating and apolipoprotein (Apo) A-1-elevating efficacy than atorvastatin in patients with hypercholesterolemia and glucose intolerance (52-week PIAT study). Values are means. *P = 0.031, two-sample t test. ‡P = 0.019, two-sample t test. Adapted from [24].